Abstract
Objective
The brain arteriovenous malformation (BAVM) nidus compactness score (CS), determined on angiography, predicts BAVM recurrence after surgical resection among children with sporadic BAVMs. We measured the angiographic CS for BAVMs among children with hereditary hemorrhagic telangiectasia (HHT) to determine CS characteristics in this population.
Methods
A pediatric interventional neuroradiologist reviewed angiograms to determine the CS of BAVMs in children with HHT recruited to the BVMC. CS is based on overall nidus and perinidal anomalous vessel compactness. CS categories included 1 = diffuse nidus, 2 = intermediate nidus, and 3 = compact nidus.
Results
Forty-eight of 78 children (61.5%) with HHT and brain vascular malformations had a conventional angiogram; 47 (97.9%) angiograms were available. Fifty-four BAVMs were identified in 40 of these 47 children (85.1%). Of 54 BAVMs in children with HHT, CS was 1 in 7 (13%), 2 in 29 (53.7%), and 3 in 18 BAVMs (33.3%) compared with CS of 1 in six (26.1%), 2 in 15 (65.2%), and 3 in 2 BAVMs (8.7%) among 23 previously reported children with sporadic BAVMs, p = 0.045 (Fisher’s exact). Seven children with HHT had intracranial hemorrhage: 4 had CS = 3, 1 had CS = 2, and 2 had CS = 1.
Conclusions
A range of CSs exists across HHT BAVMs, suggesting it may be an angiographic measure of interest for future studies of BAVM recurrence and hemorrhage risk. Children with HHT may have more compact niduses compared to children with sporadic BAVMs. Additional research should determine whether CS affects hemorrhage risk or post-surgical recurrence risk in HHT-associated BAVMs, which could be used to direct BAVM treatment.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request by a qualified investigator.
References
Brinjikji W, Iyer VN, Wood CP, Lanzino G (2017) Prevalence and characteristics of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis. J Neurosurg 127(2):302–310
Kilian A, Latino GA, White AJ et al (2023) Comparing characteristics and treatment of brain vascular malformations in children and adults with HHT. J Clin Med 12(7):2704
Willemse RB, Mager JJ, Westermann CJ, Overtoom TT, Mauser H, Wolbers JG (2000) Bleeding risk of cerebrovascular malformations in hereditary hemorrhagic telangiectasia. J Neurosurg 92(5):779–784
Kim H, Nelson J, Krings T et al (2015) Hemorrhage rates from brain arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia. Stroke 46:1362–1364
Easey AJ, Wallace GMF, Hughes JMB, Jackson JE, Taylor WJ, Shovlin CL (2003) Should asymptomatic patients with hereditary haemorrhagic telangiectasia (HHT) be screened for cerebral vascular malformations? Data from 22 061 years of HHT patient life. J Neurol Neurosurg Psychiatry 74:743–748
Rutledge WC, Ko NU, Lawton MT, Kim H (2014) Hemorrhage rates and risk factors in the natural history course of brain arteriovenous malformations. Transl Stroke Res 5(5):538–542
Lang SS, Beslow LA, Bailey RL et al (2012) Follow-up imaging to detect recurrence of surgically treated pediatric arteriovenous malformations. J Neurosurg Pediatr 9(5):497–504
Frisoli FA, Lang SS, Vossough A et al (2013) Intrarater and interrater reliability of the pediatric arteriovenous malformation compactness score in children. J Neurosurg Pediatr 11(5):547–551
Pawlikowska L, Nelson J, Guo DE et al (2015) The ACVRL1 c.314–35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations. Am J Med Genet A 167(6):1262–7
Akers AL, Ball KL, Clancy M et al (2013) Brain vascular malformation consortium: overview, progress and future directions. J Rare Disord 1(1):5
Spetzler RF, Martin NA (1986) A proposed grading system for arteriovenous malformations. J Neurosurg 65(4):476–483
Krings T, Kim H, Power S, Nelson J, Faughnan ME, Young WL, terBrugge KG, the Brain Vascular Malformation Consortium HHT Investigator Group (2015) Neurovascular manifestations in hereditary hemorrhagic telangiectasia: imaging features and genotype-phenotype correlations. Am J Neuroradiol 36:863–870
Bharatha A, Faughnan ME, Kim H, Pourmohamad T, Krings T, Bayrak-Toydemir P et al (2012) Brain arteriovenous malformation multiplicity predicts the diagnosis of hereditary hemorrhagic telangiectasia: quantitative assessment. Stroke 43:72–78
Yusuf H, Rasheed A, Kim H, Conrad MB, Hetts SW (2022) Identifying racial disparities in hereditary hemorrhagic telangiectasia. J NeuroIntervent Surg 0:1–6. https://doi.org/10.1136/neurintsurg-2022-019162
Funding
The Brain Vascular Malformation Consortium (BVMC) is part of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Office of Rare Diseases Research (ORDR). The BVMC is funded under grant number U54NS065705 as a collaboration between NCATS and the National Institute of Neurological Disorders and Stroke (NINDS). All RDCRN consortia are supported by the network’s Data Management and Coordinating Center (DMCC) (U2CTR002818). NCATS and NINDS provide funding support for the DMCC. L.A.B. was supported by a BVMC fellowship, as part of the funding detailed above. L.A.B. was also supported by the Children’s Hospital of Philadelphia Pediatrics Department Chair’s Initiative. M.E.F. was also supported by the Li Ka Shing Knowledge Institute. None of the funding sources directly participated in the study design, data collection, analysis and interpretation of data, writing of the report, or the decision to submit the article for publication.
Author information
Authors and Affiliations
Consortia
Contributions
L.A.B. wrote the original draft of the manuscript. A.V. and T.K. prepared the figures. L.A.B., M.F., and T.K. conceptualized the study. L.A.B., A.V., H.K., M.E.F., and T.K. determined the methodology for the study. L.A.B., M.E.F., and T.K. curated the data. L.A.B. and J.N. analyzed the data. M.F. and T.K. provided project administration and resources. H.K. and M.F. acquired funding. All authors participated in data collection and investigation and edited the manuscript for intellectual content.
Corresponding author
Ethics declarations
Conflict interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Previous Presentations: The abstract for this work was presented in poster form at the 14th HHT International Scientific Conference in Cascais, Portugal in September 2022 and as an oral presentation at the NIH Rare Diseases Clinical Research Network Fall Investigators’ Meeting in November 2022
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Beslow, L.A., Vossough, A., Kim, H. et al. Brain AVM compactness score in children with hereditary hemorrhagic telangiectasia. Childs Nerv Syst (2024). https://doi.org/10.1007/s00381-024-06366-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00381-024-06366-z